• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

HLA / A / B antibodies and endothelial cell responses that generate T cell subpopulation a new innovation in antibody-positive transplantation

Research Project

Project/Area Number 17K11209
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Urology
Research InstitutionAichi Medical University

Principal Investigator

Iwasaki Kenta  愛知医科大学, 医学部, 准教授 (10508881)

Co-Investigator(Kenkyū-buntansha) 小林 孝彰  愛知医科大学, 医学部, 教授 (70314010)
三輪 祐子  愛知医科大学, 医学部, 助教 (90572941)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords免疫順応 / 免疫寛容 / アロ応答 / PD-1/PD-L1 / CD4 T-cell / 移植免疫 / CD4 T細胞 / PD-L1 / TCR repertoire / alloresponse / direct recognition
Outline of Final Research Achievements

Here, we explored the role of CD4 T-cell-mediated alloresponses against endothelial HLA-DR in the presence of anti-HLA-class I or anti-A/B antibodies. CD4 T-cells, notably CD45RA-memory CD4 T-cells, undergo extensive proliferation in response to endothelial HLA-DR. The CD4 T-cell proliferative response was enhanced in the presence of anti-HLA-class I, but attenuated in the presence of anti-A/B antibodies. Microarray analysis and molecular profiling demonstrated that the expression of CD274 programmed death-ligand 1 (PD-L1) increased in response to anti-A/B ligation in endothelial cells. Amplified expression of transcript encoding PD-L1 was observed in biopsy samples from ABO-I renal transplants when compared with those from ABO-identical/compatible transplants. Taken together, our findings identified a possible factors that might prevent graft rejection and thus contribute to a favorable outcome in ABO-I renal transplantation.

Academic Significance and Societal Importance of the Research Achievements

本研究では、Direct recognition pathwayに関わるCD4 T細胞の挙動とその重要性、DSAの影響について研究を行った。今後さらなる検討知見を得るためには、実際の移植臓器でのメカニズム解明が必要となる。特に実際の腎組織に浸潤しているT細胞の機能解析が必要になる、つまり、ABO不適合/適合腎移植において、腎組織でのPD-L1の高発現がどの程度の患者で確認できるのか、またその際に浸潤T細胞のサブセットに偏りが生じているのか。またそれらクローンは移植前に同定可能なのかどうかの研究を進めることで、免疫順応のメカニズム解明から治療法へとつながるはずである。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (8 results)

All 2020 2019 2018 2017

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 1 results) Presentation (5 results) (of which Invited: 2 results)

  • [Journal Article] Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis2020

    • Author(s)
      Hagihara M.、Kuroki Y.、Ariyoshi T.、Higashi S.、Fukuda K.、Yamashita R.、Matsumoto A.、Mori T.、Mimura K.、Yamaguchi N.、Okada S.、Nonogaki T.、Ogawa T.、Iwasaki K.、Tomono S.、Asai N.、Koizumi Y.、Oka K.、Yamagishi Y.、Takahashi M.、Mikamo H.
    • Journal Title

      iScience

      Volume: 23 Issue: 1 Pages: 100772-100772

    • DOI

      10.1016/j.isci.2019.100772

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantation2019

    • Author(s)
      Okada Manabu、Watarai Yoshihiko、Iwasaki Kenta、Futamura Kenta、Yamamoto Takayuki、Hiramitsu Takahisa、Tsujita Makoto、Goto Norihiko、Narumi Shunji、Takeda Asami、Kobayashi Takaaki
    • Journal Title

      Human Immunology

      Volume: 80 Issue: 3 Pages: 169-175

    • DOI

      10.1016/j.humimm.2018.12.004

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Suppressive effect of everolimus on IL-2, IL-10, IL-21, and IFNγ levels: Implication for successful minimization of calcineurin inhibitor use in transplantation2019

    • Author(s)
      Kenta Iwasaki, Nana Kitahata, Yuko Miwa, Kazuharu Uchida, Matsuoka Yutaka, Kosei Horimi, and Takaaki Kobayashi
    • Journal Title

      Therapeutic Drug Monitoring

      Volume: Mar 29 Issue: 3 Pages: 371-375

    • DOI

      10.1097/ftd.0000000000000630

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Presentation] 抗体関連型拒絶反応抵抗性獲得メカニズムに関する研究2019

    • Author(s)
      岩﨑研太
    • Organizer
      第55回日本移植学会総会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] 長期生着時代の免疫抑制剤の課題と展望2019

    • Author(s)
      岩﨑研太
    • Organizer
      第63回大阪腎移植病理組織研究会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] 内皮細胞HLA-class II DRとアロ応答するPD-1+CD25+foxp3+CD4 T細胞の機能解析2019

    • Author(s)
      岩﨑研太
    • Organizer
      第28回日本組織適合性学会大会
    • Related Report
      2019 Annual Research Report
  • [Presentation] MEK阻害剤はIFNγ刺激内皮細胞でPD-L1を上昇させ、MHC class II応答性CD4を減弱させる2018

    • Author(s)
      岩﨑研太、三輪祐子 、打田和治 、小林孝彰
    • Organizer
      第45回臓器保存生物医学会
    • Related Report
      2018 Research-status Report
  • [Presentation] 内皮細胞HLA-class II DRとアロ応答するCD4 T細胞は、anti-A/B 抗体接着により抑制される2017

    • Author(s)
      64.岩﨑研太、三輪祐子、打田和治、堀見孔星、松岡裕、岡田学、浜名洋、岸裕幸、村口篤、小林孝彰
    • Organizer
      第26回日本組織適合性学会
    • Related Report
      2017 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi